At ATS 2025, data from the Phase III MATINEE trial reinforced the efficacy of Nucala in reducing exacerbations in COPD ...

MSD Animal Health, a division of Merck & Co, Inc, announced that it has received FDA approval for its gentamicin, posaconazole, and mometasone furoate otic suspension (Mometamax Single; Merck). This ...